Advitech

Mr. Claude R. Livernoche joined the Board of Advitech as non-executive Chairman in 2002. His role is to assist the management of the Corporation in carrying out its growth strategy and to provide advice on certain aspects of Advitech’s day-to-day operations. Mr. Livernoche graduated as an engineer from l’École Polytechnique (1964) and holds an MBA degree from l’École des Hautes Études Commerciales (1973). He has been a senior manager with several leading Canadian companies (Quebecor, Tafisa-Sonae, Quno and Abex Industries). He is now president and chief executive officer of Corporation Innovation – Papier, an investment Corporation. Mr. Livernoche is also a director, since November 2003, of TechCana Inc., a company listed on the TSX Venture Exchange.

Mr. Renaud Beauchesne, Executive Chairman has been with Advitech since its inception. Before founding Advitech, Mr. Beauchesne was a partner of Zins, Beauchesne & Associés, a subsidiary of Secor Group, a major Canadian consulting firm specializing in marketing and strategic planning with offices in Québec, Montréal, Ottawa and Paris (France). During this part of his professional career, Mr. Beauchesne developed a strong expertise in the development of bio-food and biotech companies, as well as strong ties with companies such as IngrediA, Agropur, Nestlé, Novartis and others companies active in nutraceutical markets. Mr. Beauchesne has an MBA degree from Université Laval (Québec, Canada).

Mr. Louis Lacasse has been President of GeneChem Management inc. since 1997 and Managing Partner of AgeChem Financial Inc. since 2006. GeneChem and AgeChem are managing three life sciences venture capital funds which have invested in more than forty (40) companies in Canada, USA and Europe. Prior to joining GeneChem, Mr Lacasse worked at the Caisse de dépôt et de placement du Québec, where he held several positions between 1987 and 1997, including vice-president of Sofinov, a private placement subsidiary of the Caisse which focussed on biotechnology, information technology and industrial technology. Before joining the Caisse, Mr Lacasse worked as a financial analyst with the National Bank of Canada, as account manager at the Bank of Montreal and as project manager at the Centre de Développement Technologique. He has also owned a small retail company. Mr. Lacasse has been appointed to the boards of directors of many private and public companies. Among these we find BioChem Pharma Inc., Axcan Pharma Inc., Targeted Genetics Inc., Methylgene Inc. and Idun Pharmaceuticals Inc. He is currently on the board of four publicly traded companies, Chairman of two audit committee and Chairman of one compensation committee. He holds a bachelor’s degree in finance from the École des Hautes Études Commerciales and an MBA from McGill University.

Mr. Pierre Labbé is Vice-President, Chief Financial Officer and Secretary of Plexmar Resources since May 2007. Mr. Labbé has close to twenty years of experience in administration and finance. Before joining Plexmar Resources, Mr. Labbé was Vice-President, Chief Financial Officer and Secretary of Medicago Inc. from July 2004 to May 2007, Vice-President of Finance and Secretary of Séquoia Minerals Inc. from December 2003 to June 2004 and of Mazarin Inc. from March 2000 to December 2003, while both companies were listed on the Toronto Stock Exchange. Prior to March 2000, he held management positions in accounting and finance with Agrinove, an agri-food cooperative and Coopers & Lybrand, now PricewaterhouseCoopers LLP where he was involved in many acquisitions and public financing projects. Mr. Labbé holds a Bachelor’s degree in Business Administration and an accounting license from Université Laval, (Québec, Canada), and he is a member of the Ordre des comptables agréés du Québec and of the Canadian Institute of Chartered Accountants.

Mr. Richard Bordeleau is currently the Executive Vice-President of BioCad Medical, a high-tech company specialized in computer-aided design and manufacturing of dental and medical prosthesis located in Quebec City. Prior to joining BioCad, from 2001 to September 2007, he was President of Atrium Innovations’ Health and Nutrition division after holding the position of Vice-President of that company for one year in 2000. Previously, he occupied various positions on the management team of Æterna Zentaris, a biopharmaceutical company where he started in February 1994 as Director of Marketing and become its Senior Vice-President, Corporate Development from 1998 until 2000. Throughout his career, he focused on developing strong organic and external growth through international development, strategic alliances and acquisitions.